Samsara BioCapital, L.P.
SEC CIK 1699737 · EDGAR
BoughtSold
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Slingsby Brian Taylor | Dir, 10% | — | $3.01M |
| 8 | Gold Alexander M | Dir | — | $1.58M |
| 9 | Karydas Daphne | Dir | — | $925.6K |
| 10 | DiRocco Derek | Dir | — | — |
Samsara BioCapital, L.P. made no open-market trades at MLYS in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-17 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital, L.P. | 10% | P - Purchase | $13.50 | +600.0K | 5.67M | +12% | +$8.10M |
| DI | 2024-12-06 | 2024-03-05 | VTVT | vTv Therapeutics Inc. | Samsara BioCapital, L.P. | 10% | J - Other | — | -58.8K | 206.8K | -22% | — |
| I | 2024-02-14 | 2024-02-12 | MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital, L.P. | 10% | P - Purchase | $13.50 | +555.6K | 5.07M | +12% | +$7.50M |
| I | 2021-12-20 | 2021-12-15 | LENZ | LENZ Therapeutics, Inc. | Samsara BioCapital, L.P. | 10% | P - Purchase | $10.19 | +22.3K | 7.81M | +0.3% | +$227.5K |
| MI | 2021-10-15 | 2021-10-13+ | LENZ | LENZ Therapeutics, Inc. | Samsara BioCapital, L.P. | 10% | P - Purchase | $13.14 | +50.8K | 7.58M | +0.7% | +$667.7K |
Purchase Sale Sale after option exercise All abbreviations